Blood Testing Market Overview
Blood testing is a laboratory examination performed on blood sample taken from patient’s body with the assist of needle or finger pierce to decide the situation of health. The function of organs and how well healing is going on can be determined by blood culture tests. These tests are very widespread and even the usual checkups might require one.
Elevated growth in this market can be accredited to the rising number of blood donations and blood donors, increasing awareness about safety of donated blood, increasing demand for donated blood, and growing occurrence of infectious diseases. However, lack of proper training amid medical technicians in developing countries and other resource poor nations is likely to hinder the revenue growth of the Blood Testing market.
Blood Testing Market Forecast Report (2018-2023)
Global Blood Testing Market was worth $55.58 billion in 2018 and estimated to be growing at a CAGR of 2.6%, to reach $63.19 billion by 2023
Browse Report Brief and TOC @ https://marketdataforecast.com/market-reports/blood-testing-market-1405/
Blood Testing Market Segmentation
The global Blood Testing market is segmented on the basis of type into Complete Blood Count, Blood Chemistry Tests, Blood Enzymes Tests and Blood Clotting Tests. Complete Blood Count segmented is further divided into Red Blood Cells, White Blood Cells, Haemoglobin, Hematocrit and Platelets. Blood Chemistry Tests are bifurcated among Test for Electrolytes, Blood Glucose, Calcium and Test for Kidney Function. Blood Enzymes Tests are sub segmented into Troponin and Creatine Kinase. Blood Clotting Tests Segment is segregated among Prothrombin time and Activated Partial Thromboplastin time and Blood Coagulation. On the basis of diseases the market is divided into Anaemia, Infection, Leukaemia, Hypokalemia, Kidney Disorders, Heart Attack and Coronary Heart Disease. Based on Methods, market is bifurcated among Manual Blood Culture Testing and Automated Blood Culture Testing. Automated Blood Culture Testing division is further sub segmented into Automated Blood Culture System and Blood Culture Instruments.
Based on geography the market is analysed under various regions namely, North America, Latin America, Europe, Asia-Pacific and Middle-East & Africa. North America dominates the blood screening market, with the U.S. holding a major market share. On the other hand, Asia-Pacific is poised to grow at the maximum CAGR during the forecast period. Growing occurrence and incidence of communicable diseases, high demand for donated blood, and improved awareness among people about the safety of donated blood are propelling the blood testing market in this region.
The major companies dominating this market for its products and services are
- Bio-Rad Laboratories Inc. (U.S.),
- Siemens Healthcare (Germany),
- Grifols (Spain),
- Nanosphere Inc. (U.S.),
- BioMérieux (France),
- Dickinson and Company (U.S.),
- Ortho Clinical Diagnostics Inc. (U.S.),
- Roche Diagnostics (Switzerland),
- Alere Inc. (U.S.),
- Bruker Corporation (U.S.),
- Abbott Laboratories (U.S.),
- Thermo Fisher Scientific Inc. (U.S.)
- Beckman Coulter (U.S.).
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.
For more information:
Sales Manager at Market Data Forecast